JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr | ₹4,088 Cr | ₹4,420 Cr |
What is the latest Total Non-Current Liabilities ratio of JUBILANT PHARMOVA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹3,765 Cr |
Mar2022 | ₹2,922 Cr |
Mar2021 | ₹2,973 Cr |
Mar2020 | ₹4,088 Cr |
Mar2019 | ₹4,420 Cr |
How is Total Non-Current Liabilities of JUBILANT PHARMOVA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹3,765 Cr | 28.87 | |
Mar2022 | ₹2,922 Cr | -1.73 | |
Mar2021 | ₹2,973 Cr | -27.27 | |
Mar2020 | ₹4,088 Cr | -7.53 | |
Mar2019 | ₹4,420 Cr | - |
Compare Total Non-Current Liabilities of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹10,798.9 Cr | -1.2% | 14.7% | 119.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -1.2% |
14.7% |
119.8% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses